GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » EDX Medical Group PLC (AQSE:EDX) » Definitions » EV-to-Revenue

EDX Medical Group (AQSE:EDX) EV-to-Revenue : (As of Jun. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is EDX Medical Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, EDX Medical Group's enterprise value is £0.00 Mil. EDX Medical Group does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate EDX Medical Group's EV-to-Revenue at this moment.

The historical rank and industry rank for EDX Medical Group's EV-to-Revenue or its related term are showing as below:

AQSE:EDX's EV-to-Revenue is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 3.1
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-19), EDX Medical Group's stock price is £0.075. EDX Medical Group does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate EDX Medical Group's PS Ratio at this moment.


EDX Medical Group EV-to-Revenue Historical Data

The historical data trend for EDX Medical Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EDX Medical Group EV-to-Revenue Chart

EDX Medical Group Annual Data
Trend
EV-to-Revenue

EDX Medical Group Semi-Annual Data
EV-to-Revenue

Competitive Comparison of EDX Medical Group's EV-to-Revenue

For the Diagnostics & Research subindustry, EDX Medical Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EDX Medical Group's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, EDX Medical Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where EDX Medical Group's EV-to-Revenue falls into.



EDX Medical Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

EDX Medical Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/
=


EDX Medical Group  (AQSE:EDX) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EDX Medical Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.075/
=


EDX Medical Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of EDX Medical Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


EDX Medical Group (AQSE:EDX) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
210-211 Milton Road, Cambridge, GBR, CB4 0WA
EDX Medical Group Plc develops and validates digitally enabled diagnostic products and services to help predict disease risk, inform clinical decision-making and accelerate the development of new medicines in the areas of cancer, heart disease, neurology and infectious diseases.

EDX Medical Group (AQSE:EDX) Headlines

No Headlines